Skip to content

Effect of Products on skin ageing

To evaluate the in-vivo efficacy and safety of a skin care formulation in terms of reduction in wrinkles & fine lines, improvement in smoothness, skin even tone, skin moisturisation, skin firmness, elasticity, Trans Epidermal Water loss & skin Luminosity on healthy female subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073276
Enrollment
36
Registered
2024-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: K Sugandh body oil: Product is applied on whole face and body, twice in a week for period of 28 days Control Intervention1: NIL: NA

Sponsors

Kama Ayurveda Pvt Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Indian female subjects 2. Healthy subjects 3. Skin is healthy on the studied anatomic unit 4. Having Crows feet wrinkle of grade 2 and above according to the Bazins atlas. 5. Having varied skin type & sensitive skin type

Exclusion criteria

Exclusion criteria: 1. Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2. Having refused to give his/her assent by not signing the consent form 3. Taking part in another study liable to interfere with this study 4. Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less 5. than 6 months) 6. Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 7. months) 8. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic 9. products or food products. 10. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes(the only medication permitted is paracetamol). 11. Having cutaneous hypersensitivity. 12. Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

Design outcomes

Primary

MeasureTime frame
Reduction in wrinkles & fine lines, improvement in smoothness, skin even tone, skin moisturisation, skin firmness, elasticity, Trans Epidermal Water loss & skin LuminosityTimepoint: Baseline, Day 14, Day 28

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

poojayadav@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026